BrightSpring Health Services, Inc. (BTSG)
NEUTRALファンダメンタル
67
株価
$56.63
時価総額
$11.62B
パート1 · 企業の価値
概要
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
貸借対照表と流動性
売上高
$14.37B
直近12か月（2026/6/30まで）
純利益
$366M
直近12か月（2026/6/30まで）
フリーキャッシュフロー
$395M
自己資本合計
$1.88B
負債合計
$4.53B
流動比率
1.59
利払い倍率
2.94
負債/EBITDA
5.20
一株当たり利益（EPS）
売上高と純利益
フリーキャッシュフロー
収益内訳
財務推移表
利益率の推移
負債の推移
負債の重さ
成長率グリッド
成長率 — 売上高
適正価値の推定
適正価値
$71.31
現在株価
$56.63
安全マージン
+20.6%
適正価値レンジ
$56.87 - $85.75
推定方法
バリュエーション指標
P/E レシオ
36.05
ROE
10.2%
P/B レシオ
5.75
P/FCF
29.26
粗利益率
12.4%
ROIC
8.0%
収益性レーダー
Value Creation (Economic Moat)
ROIC
8.0%
WACC
13.2%
ROIC − WACC
-5.2 pp
ROIC is below the cost of capital — the company is destroying value for every dollar invested.
ファンダメンタル分析基準
合格（18）
- EPS shows upward trend
- Price CAGR 86.00%
- ROIC 8.0%
- P/FCF 29.26
- Debt/Equity ratio
- Positive Free Cash Flow
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 19.0%
- Revenue Growth 5Y 18.3%
- Analyst Consensus 96% Buy
- Earnings Surprise avg 17.2%
- PEG Ratio 0.68
- Earnings Quality (OCF/NI) 1.38
- Net Margin Trend 2.5% vs 0.6%
- Piotroski F-Score 7/9
不合格（8）
- Gross Margin 12.4%
- P/B Ratio 5.75
- Operating Margin 3.1%
- CapEx intensity
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Share Dilution 9.2%
データなし（1）
- Dividend Payout NaN%
Piotroski F-スコア
財務健全性が高い
利益の質
高品質：利益はキャッシュに裏付けられている
株式希薄化
新株を発行しており、所有権を希薄化している
ガバナンス
経営陣
| 氏名 | 役職 | 年齢 |
|---|---|---|
| Mr. Jon B. Rousseau | Chairman, President & CEO | 51 |
| Ms. Jennifer A. Phipps | CFO, Executive VP & Corporate Secretary | 44 |
| Ms. Lisa Nalley | Chief of Staff & Senior VP of Human Resources | 52 |
| Ms. Jennifer Yowler | Senior VP of Sales & Account Management - PharMerica | 48 |
| Mr. Scott Greenwell Pharm.D. | Executive VP & President of PharMerica | - |
| Mr. Charles H. Wardrip | Chief Information Officer | - |
監査リスク
7
取締役会リスク
9
報酬リスク
8
株主権利リスク
8
パート2 · 株価と買い時
この部分は企業に価値があるかを判断するものではありません。ファンダメンタルズに納得したうえで、いつ買うかを選ぶためのものです。内容：テクニカル分析、ポテンシャル、過去のドローダウン、ガンマエクスポージャー。
Latest News
Recent headlines for BTSG, sourced from Markets Gazette.
- 2/27/2026NEUTRALBrightSpring (BTSG) Earnings Call Transcript
Markets Gazette reports that BrightSpring Health Services, Inc. (BTSG) held its earnings call on February 27, 2026. However, the detailed content of the transcript is not yet publicly available. Without access to specific financial data, future guidance, or management commentary, investors lack concrete elements to assess the company's performance or outlook. The absence of information prevents a clear directional analysis, leaving the stock in a holding pattern. The market will remain in suspense until the details are published, which could then trigger significant movements once key data points are released.
via Markets Gazette